AI does not replace experiments: it makes them targeted, faster and far less costly. In health, nutrition and cosmetics, natural actives taking the place of synthetic molecules is moving within reach. One condition remains: the same plant must deliver the same chemistry, batch after batch. That is why, at BotaniX, we grow our plants in controlled conditions, so that what AI discovers can be reproduced.

Indoor aeroponic cultivation removes the environmental conditions that create each of these contamination categories. There is no soil, so there are no soil-borne heavy metals, no soil-borne pathogens, and no pesticide residues from agricultural activity. There are no adjacent fields, so there is no drift contamination.

Supplying a botanical extract for cosmetics or food supplements is one thing. Supplying a starting material for a human clinical trial is something entirely different. It requires an entirely different regulatory and operational framework: ✔️ Complete batch-to-batch consistency ✔️ Full traceability from plant genetics to final material ✔️ Validated analytical methods ✔️ Pharmacopoeial contaminant control ✔️ Compliance with GACP and pharmaceutical regulatory requirements

Medicinal Plants | ~4 min read The market is splitting in two and pharma-grade botanical nutraceutical is one of them For years, the nutraceutical industry sourced botanical ingredients the same way the food industry sourced spices: in bulk, from commodity suppliers, with minimal documentation beyond a basic certificate of analysis. The primary selection criteria were price per kilogram and availability. For many products, this was adequate. A dried leaf blend destined for